F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump
Sunday, 22 November 2020 () The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
The FDA approved remdesivir as a treatment for severe COVID-19 cases last month. This is after granting emergency authorization in May, reports Business Insider. But on Thursday, the WHO announced it will not recommend the drug's use for COVID-19 patients. "There is currently no evidence that it...
Drug company Eli Lilly has received emergency use authorization for its antibody drug, which is similar to the antibody drug President Trump received, but there have been numerous antibodies in various..